Evidence map›Paper›PMID 42379769›Full record

ArticleIn vivo (Athens, Greece)

Antioxidant and Neuroprotective Effects of 20% Marigold Extract Oil (Lutein/Zeaxanthin Complex) in LED-induced Retinal Injury and A2E-mediated ARPE-19 Models.

Young-Hoon Kim, Dong-Hee Kim, Jung-Mo Ahn, Hyo-Jun Kim, Yun-Chan Jung, Hee-Woo Lee

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Young-Hoon Kim *Institute of Research and Development, Chaon Corp., Yongin, Republic of Korea.
Dong-Hee Kim *Institute of Research and Development, AK Biolink Corp., Seoul, Republic of Korea.
Jung-Mo AhnInstitute of Research and Development, Chaon Corp., Yongin, Republic of Korea.
Hyo-Jun KimInstitute of Research and Development, ChongKunDang Healthcare Corp., Seoul, Republic of Korea.
Yun-Chan JungInstitute of Research and Development, Chaon Corp., Yongin, Republic of Korea; chaon@chaon.kr.
Hee-Woo LeeInstitute of Research and Development, Chaon Corp., Yongin, Republic of Korea; dinks90@chaon.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimLutein and zeaxanthin (L/Z) are major components of macular pigment with established antioxidant and blue-light filtering properties. This study investigated the protective efficacy of a 20% marigold extract oil (L/Z complex) using both an A2E-mediated ARPE-19 cell MATERIALS AND

methods

resultsIn ARPE-19 cells, A2E-mediated blue light exposure reduced viability to 28.15±3.67% and markedly increased inflammatory cytokines. L/Z complex significantly reduced NF-κB, interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) expression while enhancing HO-1 and antioxidant enzyme levels. In the rat model, L/Z complex preserved outer nuclear layer (ONL) thickness, reduced pro-inflammatory cytokines, enhanced total antioxidant capacity (TAC) and glutathione peroxidase (GSH-Px) activities, and attenuated NF-κB expression.

conclusionThe L/Z complex confers retinal protection through coordinated antioxidant and anti-inflammatory mechanisms in both cellular and animal models of retinal injury, supporting its translational potential as a nutritional intervention for retinal degeneration.

Indexed as

AntioxidantsLuteinNeuroprotective AgentsPlant ExtractsRetinaZeaxanthinsAnimalsBlue LightCell LineCell SurvivalCytokinesDisease Models, AnimalHumansMaleNF-kappa BOxidative StressAntioxidantsCytokinesLuteinNeuroprotective AgentsNF-kappa BPlant ExtractsZeaxanthinsantioxidantLuteinmarigold extractneuroprotectionretinal injuryzeaxanthin

Identifiers

PMID42379769
PMCPMC13322001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.